An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction
Sharma Kattel1, Salim Memon2, Keiko Saito2
1Department of Medicine, Sisters of Charity Hospital, University at Buffalo, Buffalo, NY, USA; Division of Hospital Medicine, Mayo Clinic Health System, Albert Lea/Austin, MN, USA.
Insights
Left ventricular hypertrophy (LVH) may predict worsening diastolic dysfunction in patients with mild-to-moderate left ventricular diastolic dysfunction (LVDD). LVH presence correlated with higher filling pressures and impaired global function, suggesting a risk for future diastolic heart failure.
Area of Science:
- Cardiology
- Echocardiography
- Heart Failure Research
Background:
- Left ventricular diastolic dysfunction (LVDD) is linked to various conditions, often induced by left ventricular hypertrophy (LVH).
- The predictive role of LVH in the progression of LVDD to diastolic heart failure remains unclear in patients with existing mild-to-moderate LVDD.
Purpose of the Study:
- To investigate the impact of LVH on left ventricular diastolic function in patients diagnosed with mild-to-moderate LVDD.
- To determine if LVH is a predictor of future LVDD deterioration.
Main Methods:
- A comparative study involving 225 patients with LVH and 225 without LVH, all having mild-to-moderate LVDD and preserved ejection fraction.
- LVDD assessment utilized Doppler mitral inflow and tissue Doppler patterns.
- Key parameters evaluated included estimated left ventricular filling pressure (FP) and the Tei index for global function, alongside isovolumic relaxation time (IVRT).
Main Results:
- Patients with LVH exhibited significantly higher left ventricular filling pressures (15.68 mmHg vs. 14.07 mmHg) compared to those without LVH.
- The Tei index, indicating global left ventricular function, was significantly elevated in the LVH group (0.58 vs. 0.53).
- Isovolumic relaxation time (IVRT), a measure of diastolic function, was significantly longer in the LVH group (103.93 ms vs. 95.94 ms).
Conclusions:
- The presence of LVH in patients with mild-to-moderate LVDD is associated with elevated filling pressures and impaired global left ventricular function.
- These findings suggest that LVH may serve as a predictor for the progression to severe LVDD and the development of diastolic heart failure.
Objectives:
Left ventricular diastolic dysfunction (LVDD) is associated with a variety of medical conditions. Left ventricular hypertrophy (LVH) is one of the most common abnormalities that induce LVDD. However, it is unclear whether LVH is a predictor of future LVDD deterioration that leads to diastolic heart failure in patients who already have mild-to-moderate LVDD. In this study, we investigated the effect of LVH on LV diastolic function in mild-to-moderate LVDD patients.
Methods:
Of the patients with mild-to-moderate LVDD (Grade I and II) with preserved left ventricular ejection fraction (EF), 225 with LVH (LVH group) and 225 without LVH (non-LVH group) were consecutively selected. LVDD was defined by the abnormal patterns of Doppler mitral inflow and tissue Doppler. Left ventricular filling pressure (FP) was estimated by the following formula: 1.9 +1.24× [early mitral inflow velocity (E)/early mitral annular velocity (e')]. The Tei index was implemented to assess global (both systolic and diastolic) left ventricular function. Echocardiographic parameters for LVDD, such as isovolumic relaxation time (IVRT), were compared between the two groups.
Results:
FP and Tei index were significantly higher in the LVH group compared to the non-LVH group [15.68 mmHg vs. 14.07 mmHg, P < 0.0001, and 0.58 vs. 0.53, P < 0.003, respectively]. IVRT was significantly longer in the LVH group than in the non-LVH group [103.93 ± 23.93 vs. 95.94 ± 20.16, P < 0.0001].
Conclusions:
In mild-to-moderate LVDD patients, both FP and the Tei index were significantly higher when LVH was present. This may suggest LVH as a possible predictor for the future development of severe LVDD and diastolic heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy


